UNITED CLINICAL TRIALS NETWORK Trademark

Trademark Overview


On Sunday, March 3, 2024, a trademark application was filed for UNITED CLINICAL TRIALS NETWORK with the United States Patent and Trademark Office. The USPTO has given the UNITED CLINICAL TRIALS NETWORK trademark a serial number of 98431010. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, September 18, 2024. This trademark is owned by United Clinical Trials Network, LLC. The UNITED CLINICAL TRIALS NETWORK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

(Based on Use) Clinical research in the field of investigational drug studies; Clinical research in the field of observational studies; Clinical research in the field of medical device studies; Pharmaceutical research and development; Pharmaceutical research services; Consulting services for others in the field of design, planning, and implementation project management of pharmaceutical research; Consulting services for others in the field of design, planning, and implementation project management of clinical research trials; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Providing a website featuring educational information in the field of clinical research; Providing information in the field of clinical research via a website; Technical consulting in the field of pharmaceutical studies (Based on Intent to Use) Research and development in the pharmaceutical and biotechnology fields; Research and...
united clinical trials network

General Information


Serial Number98431010
Word MarkUNITED CLINICAL TRIALS NETWORK
Filing DateSunday, March 3, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, September 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of light blue, medium blue, and dark blue intersecting circles to the left of the wording "united" in black lowercase letters, above the wording "CLINICAL TRIALS NETWORK" in black capitalized letters, and a white background.
Indication of Colors claimedThe color(s) white, black, light blue, medium blue, and dark blue is/are claimed as a feature of the mark.
Goods and Services(Based on Use) Clinical research in the field of investigational drug studies; Clinical research in the field of observational studies; Clinical research in the field of medical device studies; Pharmaceutical research and development; Pharmaceutical research services; Consulting services for others in the field of design, planning, and implementation project management of pharmaceutical research; Consulting services for others in the field of design, planning, and implementation project management of clinical research trials; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Providing a website featuring educational information in the field of clinical research; Providing information in the field of clinical research via a website; Technical consulting in the field of pharmaceutical studies (Based on Intent to Use) Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research on the subject of pharmaceuticals; Basic and clinical research in the field of respiratory science and medicine; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Laboratory research in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Providing medical research information in the field of pharmaceuticals; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing scientific research information in the field of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of investigational drug studies; Scientific research in the nature of conducting clinical trials for others in the field of observational studies; Scientific research in the nature of conducting clinical trials for others in the field of medical device studies; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, March 3, 2024
Primary Code042
First Use Anywhere DateTuesday, June 6, 2023
First Use In Commerce DateTuesday, June 6, 2023

Trademark Owner History


Party NameUnited Clinical Trials Network, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRockford, MI 49341

Trademark Events


Event DateEvent Description
Sunday, July 14, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, July 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 18, 2024ASSIGNED TO EXAMINER
Sunday, March 3, 2024NEW APPLICATION ENTERED